SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $961,353 | -71.8% | 41,581 | -68.0% | 0.27% | -77.3% |
| Q2 2023 | $3,408,600 | -31.7% | 130,000 | -25.7% | 1.19% | -14.6% |
| Q3 2022 | $4,993,000 | -78.3% | 175,000 | -57.0% | 1.39% | -62.1% |
| Q1 2022 | $22,971,000 | +24.1% | 407,000 | +36.3% | 3.68% | -45.3% |
| Q4 2021 | $18,504,000 | +131.5% | 298,545 | +136.9% | 6.72% | +232.8% |
| Q3 2021 | $7,994,000 | +288.1% | 126,013 | +404.1% | 2.02% | +173.9% |
| Q2 2021 | $2,060,000 | +3.7% | 25,000 | -7.4% | 0.74% | +9.3% |
| Q1 2021 | $1,986,000 | – | 27,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |